Aldeyra gets second CRL for dry eye disease drug

The FDA once again rejected Aldeyra's potential dry eye disease treatment, known as reproxalap, as the agency requested more trial data after the resubmitted drug approval request "failed to demonstrate efficacy in adequate and well ...

Apr 3, 2025 - 15:54
 0
Aldeyra gets second CRL for dry eye disease drug
The FDA once again rejected Aldeyra's potential dry eye disease treatment, known as reproxalap, as the agency requested more trial data after the resubmitted drug approval request "failed to demonstrate efficacy in adequate and well ...